SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Felix B who wrote (2125)6/6/2017 11:40:41 PM
From: Miljenko Zuanic  Respond to of 3559
 
Means that as of cut-off date more than 1/2 subjects still receive treatment and they did not progress, so PFS should be better than historical (but, historical may not mean much). Anyway, many thinks (and I too) that their P2 will be sufficient for BLA.

On a today court note, seams that Sanofi do not care much.
secfilings.nasdaq.com